Let's break down Fortis Healthcare (India) Ltd. (FORTIS) — from its financial performance to how the market is valuing the stock.
Fortis Revenue Trend
At ₹9,128 Cr, Fortis Healthcare (India) Ltd.'s FY2026 revenue was 17.3% ahead of the ₹7,783 Cr posted in FY2025.
The 10-year revenue CAGR of 7.9% reflects steady — if not spectacular — top-line expansion from ₹4,265 Cr to ₹9,128 Cr.
At ₹9,128 Cr in annual revenue, Fortis Healthcare (India) Ltd. is one of the mid-sized players in the healthcare space.
The consistency stands out: 5 consecutive years of growth in top-line revenue.
| Year | Revenue | YoY % |
|---|---|---|
| FY2026 | ₹9,128 Cr | +17.3% |
| FY2025 | ₹7,783 Cr | +12.9% |
| FY2024 | ₹6,893 Cr | +9.5% |
| FY2023 | ₹6,298 Cr | +10.1% |
| FY2022 | ₹5,718 Cr | — |
View Fortis Healthcare (India) Ltd.'s full 10-year revenue trend with CAGR analysis →
Fortis Profitability
On the profitability front, Fortis Healthcare (India) Ltd. did well — net income rose 31.5% to ₹1,064 Cr from ₹809 Cr a year earlier.
The company squeezed out better margins in FY2026, with net margin at 11.7% versus 10.4% in FY2025.
Looking at per-share numbers, diluted EPS was ₹13.80 in FY2026 — up from ₹10.26.
Is Fortis Undervalued
Fortis Healthcare (India) Ltd. shares are currently trading at ₹940.00.
Craytheon calculates intrinsic value using the P/E Ratio, DCF, and EPS Growth models. All three appear in the Valuation Models cards below.
Valuation Models
Fortis Shareholding Pattern
Promoters continue to hold 31.2% of the company, unchanged over recent quarters.
FII holding stands at 25.2%, down from 27.9% in the year-ago quarter.
Domestic institutional investors (DIIs) held 32.2% as of June 2026, up from 29.1% a year ago.
| Quarter | Promoter | FII | DII | Public |
|---|---|---|---|---|
| Jun 2026 | 31.2% | 25.2% | 32.2% | 11.4% |
| Mar 2026 | 31.2% | 26.0% | 31.4% | 11.5% |
| Dec 2025 | 31.2% | 27.8% | 29.3% | 11.7% |
| Sep 2025 | 31.2% | 27.9% | 29.1% | 11.8% |
Track quarterly shareholding changes for Fortis Healthcare (India) Ltd. →
Fortis Balance Sheet
Proportional view as of 3 Aug 2026. Hover blocks for details.
Assets
Liabilities & Equity
FY2026 total assets: ₹159.66B (up 16.6% YoY from ₹136.92B).
Top categories: Property, Plant & Equipment (36.2%), Intangibles & Goodwill (33.5%), Other Assets (18.9%).
Of the ₹159.66B in liabilities and equity, 63.7% is shareholder equity, 21.7% is interest-bearing debt, and 14.6% is operating liabilities. Over the year, debt is up 40.3% and equity is up 10.9%.
Balance sheet composition — FY 2026
| Category | Value |
|---|---|
| Cash & ST Investments | 4.24B |
| Receivables | 10.44B |
| Inventories | 1.35B |
| Property, Plant & Equipment | 57.80B |
| Investments | 2.25B |
| Intangibles & Goodwill | 53.44B |
| Other Assets | 30.13B |
| Category | Value |
|---|---|
| Equity | 101.69B |
| Short-term Debt | 5.35B |
| Long-term Debt | 29.37B |
| Trade Payables | 9.43B |
| Other Liabilities | 13.82B |
Fortis Key Highlights
Here's the bottom line on Fortis Healthcare (India) Ltd. (FORTIS) based on the latest available financials.
Revenue of ₹9,128 Cr in FY2026, up 17.3% year-over-year.
Long-term revenue has been compounding at 7.9% annually over 10 years.
The company is profitable, with a net margin of 11.7% and net income of ₹1,064 Cr.
Unlock Full Analysis
For the complete 10-year financial history with interactive charts and growth analysis, explore Fortis Healthcare (India) Ltd.'s detailed profile on Craytheon.